Cargando…
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
BACKGROUND: Mechanical ventilation in intensive care for 48 h or longer is associated with the acute respiratory distress syndrome (ARDS), which might be present at the time ventilatory support is instituted or develop afterwards, predominantly during the first 5 days. Survivors of prolonged mechani...
Autores principales: | Dixon, Barry, Smith, Roger J, Campbell, Duncan J, Moran, John L, Doig, Gordon S, Rechnitzer, Thomas, MacIsaac, Christopher M, Simpson, Nicholas, van Haren, Frank M P, Ghosh, Angajendra N, Gupta, Sachin, Broadfield, Emma J C, Crozier, Timothy M E, French, Craig, Santamaria, John D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826120/ https://www.ncbi.nlm.nih.gov/pubmed/33493448 http://dx.doi.org/10.1016/S2213-2600(20)30470-7 |
Ejemplares similares
-
A phase 1 trial of nebulised heparin in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2008) -
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
por: van Haren, Frank M. P., et al.
Publicado: (2020) -
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigator‐initiated international meta‐trial of prospective randomised clinical studies
por: van Haren, Frank M. P., et al.
Publicado: (2022) -
Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia
por: Ball, Lorenzo, et al.
Publicado: (2021) -
Nebulised heparin: a new approach to the treatment of acute lung injury?
por: Suter, Peter M
Publicado: (2008)